Nicholas J Maragakis Selected Research

Neuromuscular Diseases (Neuromuscular Disease)

6/2012

Selected statins produce rapid spinal motor neuron loss in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas J Maragakis Research Topics

Disease

21	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 02/2002
10	Disease Progression 01/2022 - 09/2006
9	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 04/2004
3	Gliosis 01/2022 - 02/2002
3	Nervous System Diseases (Neurological Disorders) 01/2018 - 04/2009
3	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2017 - 02/2002
3	Spinal Cord Injuries (Spinal Cord Injury) 09/2015 - 07/2011
2	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2012
2	Contusions 09/2015 - 07/2011
2	Stroke (Strokes) 04/2009 - 04/2004
2	Epilepsy (Aura) 04/2009 - 04/2004
1	X-Linked Bulbo-Spinal Atrophy 01/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022
1	Hereditary Spastic Paraplegia 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Embolism (Embolus) 01/2020
1	Leukocytosis (Pleocytosis) 01/2020
1	Neuroinflammatory Diseases 12/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2012
1	Neuromuscular Diseases (Neuromuscular Disease) 06/2012
1	Vascular Diseases (Vascular Disease) 06/2012
1	Hyperlipidemias (Hyperlipidemia) 06/2012
1	Crush Injuries 12/2011
1	Parkinson Disease (Parkinson's Disease) 04/2009
1	Alzheimer Disease (Alzheimer's Disease) 04/2009
1	Weight Loss (Weight Reduction) 12/2007
1	Infections 08/2004
1	Paralysis (Palsy) 08/2004
1	Central Nervous System Neoplasms 04/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
6	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 12/2015 - 02/2002
5	Glutamic Acid (Glutamate)FDA Link 12/2011 - 02/2003
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2012
3	Nerve Growth Factors (Neurotrophins)IBA 01/2020 - 12/2007
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2018
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 08/2012
3	Superoxide Dismutase-1IBA 10/2011 - 02/2002
2	Connexin 43 (Connexin43)IBA 01/2022 - 01/2016
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 08/2012
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
1	EdaravoneIBA 10/2022
1	tonabersatIBA 01/2022
1	ezogabine (retigabine)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	tofersenIBA 01/2020
1	Investigational DrugsIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 11/2018
1	Antisense OligonucleotidesIBA 01/2018
1	Superoxide DismutaseIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	RNA (Ribonucleic Acid)IBA 03/2014
1	Messenger RNA (mRNA)IBA 08/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2012
1	Biological ProductsIBA 04/2009
1	CytokinesIBA 01/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2007
1	Insulin-Like PeptidesIBA 12/2007
1	LigandsIBA 03/2006
1	AMPA Receptors (AMPA Receptor)IBA 08/2004
1	CalciumIBA 08/2004
1	Carisoprodol (Soma)FDA LinkGeneric 04/2004
1	EpitopesIBA 04/2004
1	AntibodiesIBA 04/2004
1	N-Methylaspartate (NMDA)IBA 02/2003
1	Glutamate Receptors (Glutamate Receptor)IBA 02/2003
1	Topiramate (Topamax)FDA LinkGeneric 02/2003

Therapy/Procedure

7	Therapeutics 10/2022 - 03/2006
6	Transplantation 01/2019 - 11/2008
1	Activities of Daily Living (ADL) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Denervation 09/2010